The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

Cell

Volumn 107, Issue 6, 2001, Pages 789-800

  Oh, J ^a   Takahashi, R ^a   Kondo, S ^a   Mizoguchi, A ^b   Adachi, E ^a   Sasahara, R M ^a   Nishimura, S ^a,c   Imamura, Y ^a   Kitayama, H ^a   Alexander, D B ^a   Ide, C ^b   Horan, T P ^d   Arakawa, T ^d   Yoshida, H ^a   Nishikawa, S I ^a   Itoh, Y ^e   Seiki, M ^e   Itohara, S ^c   Takahashi, C ^a   Noda, M M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d AMGEN INC   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBRIL; GELATINASE A; INTERSTITIAL COLLAGENASE; MEMBRANE PROTEIN; PROTEIN RECK; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROSARCOMA; HUMAN; HUMAN CELL; MOUSE; MUTATION; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA; MUS MUSCULUS;

EID: 18244367390     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(01)00597-9     Document Type: Article

References (48)

1. Proteolytic remodeling of extracellular matrix
2. Tissue inhibitors of metalloproteinases, evolution, structure and function
3. Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080
4. Developmental expression of MMP-9 (Gelatinase B) mRNA in mouse embryos
5. Inactivating mutation of the mouse tissue inhibitor of metalloproteinase-2 (Timp-2) gene alters proMMP-2 activation
6. MMP-9 supplied by bone marrow-derived cells contribute to skin carcinogenesis
7. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion
8. Membrane associated matrix metalloproteinases in metastasis
9. Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA
10. Blood vessel formation: What is its molecular basis?
11. RECK gene expression in hepatocellular carcinoma, Correlation with invasion-related clinicopathological factors and its clinical significance
12. Secretion of type IV collagenolytic protease and metastatic phenotype, induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a
13. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions
14. Signaling vascular morphogenesis and maintenance
15. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
16. Development of matrix metalloproteinase inhibitors in cancer therapy
17. Decreased levels of collagen mRNA in rous sarcoma virus-transformed chick embryo fibroblasts
18. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: Application of film in situ zymography
19. Unaltered secretion of β-amyloid precursor protein in gelatinase A (Matrix Metalloproteinase 2)-deficient mice
20. Matrix metalloproteinases and their inhibition in tumour growth and invasion
21. A ras-related gene with transformation suppressor activity
22. Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures
23. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
24. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases
25. Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesechymal cell death
26. Preservation of pathological tissue specimens by freeze-drying for immunohisochemical staining and various molecular biological analyses
27. Matrix metalloproteinases
28. Efficient selection for high-expression transfectants with a novel eukaryotic vector
29. Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes
30. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene
31. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
32. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
33. Changes in integrin receptors on oncogenically transformed cells
34. Molecular cloning of murine 72-kDa type IV collagenase and its expression duirng mouse development
35. Mechanisms of angiogenesis
36. Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene
37. A matrix metalloproteinase expressed on the surface of invasive tumor cells
38. Vascular endothelial cell lineage-specific promoter in transgenic mice
39. Matrix metalloproteinasese in angiogenesis: A moving target for therapeutic intervention
40. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene
41. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK
42. c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells
43. Matrix metalloproteinases, effectors of development and normal physiology
44. TIMP-2 is required for efficient activation of proMMP-2 in vivo
45. ECM and cell surface proteolysis, regulating cellular ecology
46. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection
47. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro
48. Vascular-specific growth factors and blood vessel formation